Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Climateview in its series A round of EUR 10 million
Mandate

Vinge advises Climateview in its series A round of EUR 10 million

September 29, 2021 M&A

The Swedish climate technology company Climateview has procured EUR 10 million in its series A round as part of its major investment strategy in Asia and the US.

The investment round is led by Commerz Ventures and Nordic Ninja VC. Previous funders include Sophie Stenbeck, Niklas Adalberth, Daniel Sachs and Sophia Bendz.

Climateview has developed a unique technology platform (ClimateOS) which helps cities to create and implement strategies in order to meet their climate goals.

Vinge’s team primarily consisted of Johan Larsson, Maria Dahlin Kolvi, Eléonore Friberg and Ebba Nyberg.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026